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Neoplasms and tumorlike lesions that originate from chest wall tissues 
are uncommon compared with tumors in other parts of the body, and  
unfamiliarity with these disease entities can cause diagnostic difficul-
ties for radiologists. Furthermore, the imaging features of many of these 
tumors are nonspecific, particularly those that are locally aggressive. 
However, a systematic approach based on patient age, clinical history, 
lesion location, and characteristic imaging findings often helps limit 
the differential diagnosis. Primary chest wall tumors can be classified 
as bone or soft-tissue tumors, with the latter being further classified 
into adipocytic tumors, vascular tumors, peripheral nerve sheath tu-
mors, cutaneous lesions, fibroblastic-myofibroblastic tumors, and so-
called fibrohistiocytic tumors, largely based on the 2002 World Health 
Organization classification. Within each category, it is possible to fur-
ther limit the differential diagnosis with cross-sectional imaging. Infor-
mation on specific features (eg, mineralization, fibrosis, hemosiderin 
deposits) and imaging patterns (eg, the “target sign” and “fascicular 
sign” seen in neurogenic tumors) can aid in making the diagnosis. Ra-
diologists can achieve a sufficiently specific diagnosis of bone tumors 
and soft-tissue tumors if typical findings are present.
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After reading this  
article and taking  
the test, the reader  
will be able to:
 ■Describe common 
primary chest wall 
tumors in terms 
of location, origin, 
tissue components, 
and clinical features.
 ■ Identify chest wall 
tumors on the basis 
of their MR imaging 
and CT appear-
ances.
 ■Discuss imaging 
findings that facili-
tate the differential 
diagnoses of bone 
and soft-tissue tu-
mors.
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Introduction
Tumors that arise from the chest wall (including 
bone structures such as the sternum, clavicle, 
scapula, and ribs) or from adjacent soft tissues 
are less common than are tumors in other parts 
of the body (1,2). The resulting unfamiliarity can 
make it difficult for radiologists to limit the num-
ber of possible diagnoses. Furthermore, although 
some primary tumors of the chest wall demon-
strate characteristic imaging features, many such 
tumors have nonspecific characteristics.
Lesions must be categorized to provide a 
meaningful, practical diagnostic approach, but 
any categorization of the diverse tumorous condi-
tions that affect the chest wall is arbitrary. Never-
theless, we believe that classic categorizations on 
the basis of tumor origin and tissue components 
are helpful. Accordingly, we characterize primary 
chest wall tumors as either bone tumors or soft-
tissue tumors. We subdivide bone tumors into 
malignant and benign lesions, and soft-tissue 
tumors (which are more varied) into six catego-
ries, four of which—adipocytic tumors, vascular 
tumors, fibroblastic-myofibroblastic tumors, and 
so-called fibrohistiocytic tumors—appear in the 
2002 World Health Organization (WHO) clas-
sification system for soft-tissue tumors (3). Our 
fifth and sixth categories, peripheral nerve sheath 
tumors (PNSTs) and cutaneous lesions, are not 
included in the WHO classification system for 
soft-tissue tumors but were adopted because it 
is possible to limit the differential diagnosis of 
these lesions on the basis of (a) characteristic 
imaging findings or (b) tissue layer of origin. The 
WHO classification system actually categorizes 
soft-tissue tumors into nine different groups. The 
five groups in the WHO classification system that 
we did not use—smooth muscle tumors, pericytic 
tumors, skeletal muscle tumors, chondro-osseous 
tumors, and tumors of uncertain differentia-
tion—often do not demonstrate specific imaging 
features or occur only very rarely on the chest 
wall, and they are not discussed in this article.
Instead, we discuss the radiologic, pathologic, 
and clinical features—which are important for 
limiting the differential diagnosis—of lesions that 
more commonly involve the chest wall or that 
have relatively characteristic imaging features at 
magnetic resonance (MR) imaging or computed 
tomography (CT).
Approach to Chest Wall Tumors
Irrespective of whether chest wall tumors arise 
from bone or soft tissue, many tumor entities 
largely exhibit nonspecific imaging features. 
However, substantial numbers of primary bone 
and soft-tissue tumors of the chest wall can be 
specifically diagnosed. The following criteria can 
aid in limiting the differential diagnosis of chest 
wall tumors: (a) overall prevalence and charac-
teristic clinical features, (b) mineralization pat-
terns (if any), (c) location at the chest wall, and 
(d) intrinsic MR imaging characteristics that 
correspond with histopathologic findings. As a 
diagnostic aid, we have summarized the key clini-
cal, radiologic, and pathologic features of these 
lesions in Tables 1 and 2. A bulky mass invading 
adjacent structures but demonstrating neither 
specific signal intensity characteristics at MR im-
aging nor mineralization usually raises suspicion 
for a malignant bone or soft-tissue tumor, such 
as metastasis or sarcoma. However, when miner-
alization is present within a bulky mass, osteosar-
coma and chondrosarcoma should be suspected. 
Benign bone tumors, which typically do not 
demonstrate extraosseous mass formation, may 
have imaging features that are specific enough 
to allow a pathologic diagnosis. These tumors 
include fibrous dysplasia (amorphous mineraliza-
tion), osteochondroma (continuity of the medul-
lary cavity between the lesion and affected bone), 
and enchondroma (benign osteolytic lesion with 
chondroid calcification). The following benign 
soft-tissue tumors have a distinct imaging appear-
ance: lipoma (mature fat tissue on T1-weighted 
MR images), hemangioma (high signal intensity 
on T2-weighted images, a variable amount of fat 
tissue on T1-weighted images, and a phlebolith 
on CT scans), neurogenic tumor (“target sign” 
and “fascicular sign” on T2-weighted images), 
epidermal cyst (no high signal intensity on T2-
weighted images), pilomatricoma (a calcified 
subdermal nodule with peritumoral edema on 
MR images), and elastofibroma (a fibrous mass 
located under the serratus anterior or latissimus 
dorsi muscle).
Bone Tumors
Metastatic bone tumors—including skeletal tu-
mors of the chest wall—are the most commonly 
encountered type of skeletal tumor, particularly 
in older patients (4). On the other hand, primary 
bone tumors of the chest wall are uncommon, 
accounting for only 5%–8% of all skeletal masses 
(5). Furthermore, approximately 95% of these 
primary bone tumors are located in ribs, with 
most of the remainder in the sternum (6). In this 
article, we consider the ribs, sternum, scapula, 
and clavicle to be bones of the chest wall. It 
should be remembered that sternal tumors are 
usually malignant, whereas rib lesions have an 
equal likelihood of benignancy or malignancy (7). 
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Chondrosarcoma is the most common primary 
malignant bone tumor of the chest wall and ac-
counts for 33% of all primary rib tumors, with 
myeloma being the second most common. Ewing 
sarcoma is the most common primary bone tu-
mor in children (1,8–10). Fibrous dysplasia is the 
most common benign tumorous condition of the 
osseous chest wall, accounting for approximately 
30% of these tumors (11).
Malignant Bone Tumors
Traditionally, bone tumors that demonstrate 
extensive cortical destruction and extraosseous 
soft-tissue mass formation have been categorized 
as malignant. Bone destruction is better depicted 
with CT, whereas extraosseous mass formation is 
better visualized at MR imaging. When a malig-
nant bone tumor does not have any specific imag-
ing features and demonstrates only the typical fea-
tures of a malignant lesion, limiting the differential 
diagnosis is difficult. The imaging features that aid 
in limiting the differential diagnosis of primary 
malignant tumors are described in the remainder 
of this section, with a focus on mineralization and 
signal intensity characteristics at MR imaging.
Mineralization in the matrix of a presumably 
malignant tumor is useful diagnostic information, 
making CT an important diagnostic tool. When 
mineralization shows typical chondroid features, 
such as an arc-and-ring appearance, flocculence, 
or a stippled shape, chondrosarcoma should 
be considered. The pattern of mineralization in 
chondrosarcoma has been described as nodular 
and peripheral (Fig 1) (12,13). On the other 
Table 2 
Key Clinical, Radiologic, and Pathologic Features of Primary Soft-Tissue Tumors of the Chest Wall
Tumor
Frequency, Patient 
Age,* Mineralization
Signal Intensity†  
at T1-weighted  
MR Imaging
Signal Intensity†  
at T2-weighted  
MR Imaging
Notable MR  
Imaging Feature  
or Typical Location
Adipocytic Tumors
Lipoma Common, 40–50 y, 
uncommon
Hyperintense Hyperintense Thin septa
Liposarcoma Common, 40–50 y, 
uncommon
Hyperintense (vari-
able amount of  
fat tissue depend-
ing on histologic 
type)
Hyperintense (varied 
amount of fat tissue 
according to histologic 
type)
Thick septa,  
<75% fat
Vascular Tumors
Hemangioma Uncommon, 0– 
30 y, phleboliths 
(20%–67%)
Heterogeneous  
with hyper- 
intense spot  
(fat tissue)
Heterogeneous with 
hy-perintense spot (fat 
tissue), bright vascular 
space
Variable enhance-
ment
Lymphangioma Uncommon, 1–2 y, 
rare
Iso- to  
hypointense
Bright Not applicable
Angiosarcoma Rare, ≥60 y, no  
calcification
Heterogeneous Heterogeneous Associated with 
lymphedema
PNSTs
Schwannoma Common, 20–50 y,  
uncommon
Iso- to  
hypointense
Heterogeneous signal 
intensity with a ring- 
like pattern (fascicular 
sign)‡
Degeneration 
(more common 
than in neurofi-
broma)
Neurofibroma Common, 20–30 y, 
less common than 
in schwannoma
Iso- to  
hypointense
Central hypointensity  
and peripheral hyper-
intensity (target sign)‡
Degeneration 
(more common 
in schwannoma)
Malignant  
PNST
Uncommon, 20– 
50 y, no calcifica-
tion 
Iso- to hyperintense Heterogeneously  
hyperintense
Frequent absence 
of target sign or 
fascicular sign
(Table 2 continues)
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Table 2 (continued) 
Key Clinical, Radiologic, and Pathologic Features of Primary Soft-Tissue Tumors of the Chest Wall
Tumor
Frequency, Patient 
Age,* Mineralization
Signal Intensity†  
at T1-weighted  
MR Imaging
Signal Intensity†  
at T2-weighted  
MR Imaging
Notable MR  
Imaging Feature  
or Typical Location
Cutaneous Lesions
Epidermal  
inclusion  
cyst
Common, any age, 
may be present
Variable, occasion-
ally hyperintense 
due to calcifi-
cation
Variable (not bright,  
even though a cyst)
Peripheral en-
hancement at 
the wall, subder-
mal location
Pilomatricoma Common, 0–20 y  
(40%); peak, 10– 
15 y, typically cen-
tral (80%)
Homogeneously 
isointense
Heterogeneous and  
variable
Peripheral en-
hancement at 
the capsule, sub-
dermal location
DFSP Uncommon, 20– 
40 y, no calcifi-
cation 
Hypointense Hyperintense§ Confined to sub-
dermal location 
(if small)
Fibroblastic-Myofibroblastic Tumors
Elastofibroma Common, 50–60 y,  
no calcification
Isointense with  
interspersed fat 
streak
Isointense with inter-
spersed fat streak
Bilateral (10%–
66%), near the 
lower tip of the 
scapula
Fibromatosis Common, 10–40 y; 
peak, 25–35 y, no 
calcification
Hypointense due 
to fibrous streak 
suggesting fibro-
sis and a myxoid 
component
Heterogeneous and hypo- 
intense due to fibrous 
streak suggesting 
fibrosis and a myxoid 
component
Infiltrating margin, 
heterogeneous 
enhancement
So-called Fibrohistiocytic Tumors
UPS Uncommon, ≥40 y, 
unusual
Isointense Iso- to hyperintense§ Heterogeneous 
enhancement
Note.—DFSP = dermatofibrosarcoma protuberans, PNST = peripheral nerve sheath tumor, UPS = undifferen-
tiated pleomorphic sarcoma. *Age at which tumor is most frequently recognized. †Relative to muscle. ‡Sub-
stantial overlap between the target sign and the fascicular sign. §Relative to fat.
Figure 1. Chondrosarcoma in a 36-year-old woman. (a) Contrast material–enhanced CT 
scan obtained at the level of the diaphragm shows a rib mass with chondroid calcifications 
and extensive extraosseous mass formation. (b) Photograph of the cut surface of the excised 
specimen shows a mass (maximum diameter, ~10 cm) consisting of glistening, whitish, 
lobular calcified cartilage (arrows), which corresponds to the calcifications seen at CT. The 
mass is seen invading adjacent tissue (arrowheads).
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signal voids with all MR pulse sequences, irre-
spective of disease. In osteosarcoma, mineralized 
portions of tumors have low signal intensity on 
T1- and T2-weighted images, whereas nonmin-
eralized areas and soft-tissue tumors have high 
signal intensity on T2-weighted images (17).
Benign Bone Tumors
The three most frequently encountered benign 
chest wall lesions are fibrous dysplasia, osteo-
chondroma, and enchondroma (18), whereas 
chondroblastoma, aneurysmal bone cyst (ABC), 
and giant cell tumor (GCT) are rare.
Fibrous Dysplasia.—Fibrous dysplasia is a de-
velopmental anomaly in which osteoblasts fail to 
undergo normal morphologic differentiation and 
maturation, leading to the replacement of normal 
marrow and cancellous bone by immature bone 
and fibrous stroma. Approximately 6%–20% of 
cases of monostotic fibrous dysplasia develop in 
the ribs, with 55% of cases of polyostotic fibrous 
Figure 2. Osteosarcoma in a 39-year-old man. (a) Noncontrast CT scan obtained at the level of 
the liver shows a rib mass (arrow) with central mineralization (arrowhead) near the costovertebral 
junction. (b) Axial T2-weighted MR image (repetition time msec/echo time msec = 3500/98) ob-
tained at the same level more clearly depicts the extraosseous mass (arrowhead). (c) Photograph 
of the cut surface of the excised specimen shows an ill-defined mass with whitish internal foci at 
the center (arrowheads), findings that suggest osteoid mineralization.
hand, when mineralization demonstrates typical 
osteoid features (ie, is dense, cloudy, or ivorylike), 
a diagnosis of osteosarcoma is suggested. Another 
important feature of mineralization in osteosar-
coma is that it is greatest at the center and least 
at the periphery (Fig 2) (1,9). Uncommon sub-
types of osteosarcoma, such as parosteal osteo-
sarcoma, can occur at the chest wall (Fig 3) (14). 
It should be remembered that de novo primary 
osteosarcoma of the chest wall is rare, whereas 
chondrosarcoma is the most common primary 
malignant bone tumor of the chest wall. In a se-
ries of 1274 cases, osteosarcoma was reported to  
primarily involve the rib in only 1.3% (15). In the 
absence of mineralization, more common malig-
nant bone tumors such as metastatic bone tumor, 
a hematologic malignancy, and myeloma should 
also be considered. Clinical history (patient age 
and underlying diseases) and imaging findings 
(signal intensity characteristics at MR imaging) 
aid in limiting the differential diagnosis. MR im-
aging sometimes allows further analysis of tissue 
contents. Chondrosarcomas may have high signal 
intensity on T2-weighted images, reflecting a hya-
line cartilage matrix of uniform composition with 
high water content. Contrast enhancement with 
a peripheral and septal pattern is often present 
(16). Calcifications in tumors typically appear as 
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Figure 3.  Parosteal osteosarcoma in a 41-year-old man. (a) Contrast-enhanced CT scan obtained at the midscap-
ula level shows a mass (maximum diameter, ~7 cm) surrounding the scapula from both ventral and dorsal aspects. 
The mass is densely mineralized, and its mineralized portion (arrow) crosses the medullary cavity of the scapula, a 
finding that suggests medullary involvement. (b) Axial T2-weighted MR image (3200/98) obtained at the same level 
shows the mass (arrows) as a hypointense region, reflecting dense calcification. (c) Photograph of the cut surface of 
the excised specimen shows a compactly mineralized extraosseous tumor (arrowheads) with partial involvement of 
the medullary cavity.
Figure 4. Fibrous dysplasia of a rib in a 17-year-old boy. (a) Noncontrast CT scan obtained 
at the level of the second rib shows a mass with expansile remodeling of a protracted length 
of bone. Trabeculation is seen at the periphery (arrowheads), but mineralization was not ob-
served. (b) On a coronal T2-weighted MR image (4500/120), the tumor (arrowheads) dem-
onstrates heterogeneous signal intensity. (c) Photomicrograph (original magnification, ×100; 
hematoxylin-eosin [H-E] stain) shows tissue with fibrous proliferation and osteoid formation, 
but without osteoblastic rimming (arrowheads).
dysplasia demonstrating rib involvement (19). 
Fibrous dysplasia is the most common cause of 
an osteolytic lesion by a benign tumor or tumor-
like lesion arising from the bone of the chest wall. 
It typically arises in the lateral or posterior arc of 
a rib (18), and at imaging, it shows expansile re-
modeling of a protracted length of bone. At CT, 
the fibrous dysplasia matrix may appear purely 
osteolytic or demonstrate peripheral trabecula-
tion (Fig 4) or mineralization. Fibrous dysplasia 
mineralization can appear amorphous, which 
represents woven bone formation and creates 
the typical ground-glass appearance described at 
radiography. Furthermore, fibrous dysplasia can 
contain cartilage nodules, which may demon-
strate typical cartilaginous mineralization (12). At 
MR imaging, various tissue components affect the 
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Figure 5. Osteochondroma of the scapula that resulted in scapulothoracic bursitis in an 18-year-old man. (a) Coro-
nal fat-suppressed T2-weighted MR image (5000/120) of the right posterolateral side of the chest wall reveals osteo-
cartilaginous exostosis (short arrow). Note the extensive scapulothoracic bursitis (long arrows) adjacent to the lesion, 
which was speculated to have resulted from irritation by the osteochondroma. (b) Coronal fat-suppressed T2-weighted 
MR image (5000/120) shows the lesion with a thin, hyperintense cartilage cap (arrowheads), along with scapulotho-
racic bursitis (arrows). (c) Photograph of the cut surface of the excised specimen shows the cartilage cap (arrowheads).
signal intensity characteristics of fibrous dyspla-
sia. Generally, fibrous dysplasia has signal inten-
sities ranging from low to high on T2-weighted 
images (Fig 4b), although in the majority of cases 
it has high signal intensity (20).
Osteochondroma.—Osteochondroma is a ham-
artomatous, cartilage-capped osseous growth that 
projects from the surface of the affected bone. 
Although one large series reported that solitary 
osteochondromas account for about 35%–41% 
of all benign bone tumors throughout the body 
(21), solitary osteochondromas involving a chest 
wall bone (rib, sternum, scapula, or clavicle) are 
relatively uncommon. In fact, only 8% of all rib 
tumors are osteochondromas (22), and in the 
ribs, osteochondromas show a predilection for 
the costochondral junction (23). When a solitary 
osteochondroma arises at the ventral side of the 
scapula, it sometimes causes pain related to bursa 
formation (Fig 5) (24). CT and MR imaging can 
both reveal continuity of the marrow cavity be-
tween the lesion and affected bone, the hallmark 
of osteochondroma. However, MR imaging is the 
most accurate technique for demonstrating a car-
tilage cap and for evaluating changes in involved 
adjacent structures. Cartilage caps have high 
signal intensity on T2-weighted images, as do the 
Figure 6. Enchondroma of 
a rib in a 25-year-old woman. 
(a) Contrast-enhanced CT 
scan shows a rib mass with 
cortical expansion at the cos-
tochondral junction. Note the 
punctate calcification (arrow-
head), suggesting a chondroid 
matrix. P = pancreas. (b) Pho-
tograph of the cut surface of 
the excised specimen prepared 
for microscopic examination 
(H-E stain) shows a cartilage 
matrix (arrow). Cystic space 
(C) that remained after decal-
cification corresponds to the 
calcification seen at CT.
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Figure 7. Primary ABC of the scapula in an 18-year-old woman. (a) Axial fat-suppressed 
T2-weighted MR image (4000/99) of the scapula shows a mass (maximum diameter, ~6.5 cm) 
affecting the left chest wall and consisting of multiple cysts with fluid levels. (b) Photomi-
crograph (original magnification, ×100; H-E stain) demonstrates osteoclast-like giant cells 
(arrowheads) with vacant spaces (*), which were believed to have been blood filled.
cartilaginous tissues of other tumors (23), and 
cartilage cap thickness is an important indicator 
of osteochondroma-to-sarcoma transformation. 
If the thickness of a cartilage cap exceeds 2 cm in 
adults or 3 cm in children, malignant transforma-
tion should be suspected (25).
Enchondroma.—Incarbone and Pastorino (18) 
reported enchondroma to be the second most 
common benign rib tumor after fibrous dysplasia. 
Enchondroma usually arises from cartilaginous 
tissue at the costochondral junction (18). CT re-
veals a slow-growing, lobulated, well-demarcated 
osteolytic lesion with or without bulging of cortical 
bone (Fig 6). Not all enchondromas demonstrate 
calcification at CT, and when calcification is not 
seen in the matrix, MR imaging is helpful. The 
high water content of hyaline cartilage produces 
high signal intensity on T2-weighted images, and 
the additional presence of a lobulated contour 
strongly suggests the possibility of enchondroma. 
However, enchondroma is generally considered to 
occur only rarely on the chest wall (7,26); chon-
drosarcoma is much more common. Hence, a de-
structive osseous lesion of the chest wall is initially 
suspected by the radiologist to be chondrosarcoma 
when mineralization is present (27).
Chondroblastoma.—Chondroblastoma, which 
is usually found in the epiphyseal regions of long 
bones, can occur at the chest wall and involve the 
ribs or scapulae. Furthermore, whereas chondro-
blastoma of the long bones is most commonly en-
countered in the 2nd decade of life, chondroblas-
toma of the rib is normally encountered substan-
tially later (28). Chondroblastoma typically arises 
at an ossification center, and therefore occurs 
at the costovertebral or costochondral junction 
(28). The imaging features of chondroblastoma 
can be aggressive and show ABC change, and it is 
sometimes difficult to exclude a malignant bone 
tumor. In addition, edema of adjacent bone mar-
row and soft tissue can be prominent.
Aneurysmal Bone Cyst.—ABCs can occur due 
to a secondary change of another bone tumor, 
but they can also occur as primary tumors. Most 
primary ABCs occur in patients under 30 years 
of age. At gross examination, masses are seen to 
contain a network of blood-filled cysts that his-
tologic analysis shows to be lined with fibroblasts 
and multinucleated giant cells. Typically, MR im-
aging reflects the morphologic features of the tu-
mor at gross examination and shows a lobulated 
or septated mass with a thin, well-defined rim of 
low signal intensity (29). Fluid levels are com-
monly seen within ABCs, indicating hemorrhage 
(Fig 7), but also occur in other tumors showing 
secondary ABC change; consequently, the pres-
ence of a fluid level is not pathognomonic (30).
Giant Cell Tumor.—GCTs are benign lesions 
composed of vascular sinuses lined or filled with 
abundant spindle and giant cells, and they tend 
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to occur during the 3rd or 4th decade of life. 
GCTs of the chest wall often arise in the sub-
chondral regions of flat and tubular bones, such 
as the sternum, clavicle, and ribs (23). They typi-
cally have low to intermediate signal intensity on 
T1- and T2-weighted MR images. However, one 
investigator stressed that they can have low sig-
nal intensity on these images, a finding that may 
reflect dense collagen and hemosiderin deposits 
within the tumor (Fig 8) (31,32). ABC changes 
are also common in GCTs.
Langerhans Cell Histiocytosis.—Generally, Lang-
erhans cell histiocytosis involves the osseous chest 
wall and is seen in patients under 20 years of age. 
Solitary involvement of a rib is known to account 
for approximately 9.2%–15% of eosinophilic 
granulomas, which represent the mildest subtype 
of Langerhans cell histiocytosis. CT and MR 
imaging findings are nonspecific, but perilesional 
edema can be profound, especially in the early 
phase (33).
Soft-Tissue Tumors
In adults, the most common benign soft-tissue 
neoplasm is lipoma, and the most common ma-
lignant neoplasm is undifferentiated pleomorphic 
sarcoma (UPS), a term that is used interchange-
ably with malignant fibrous histiocytoma. In chil-
dren, rhabdomyosarcoma and primitive neuroec-
todermal tumor (Askin tumor) are the most com-
mon malignant soft-tissue tumors (26). Many 
soft-tissue neoplasms share similar characteristics 
Figure 8. GCT of a rib in a 41-year-old man. (a) Contrast-enhanced CT scan obtained at the 
level of the kidney (k) shows a mass with an extraosseous portion (arrowhead) and accompanied 
by cortical destruction. Mineralization of the tumor was not observed. (b) On the corresponding 
axial T2-weighted MR image (3500/89), the tumor is heterogeneously dark, suggesting a fibrous 
component with or without chronic hemorrhage. k = kidney. (c) Photomicrograph (original mag-
nification, ×200; H-E stain) reveals multinucleated giant cells (arrowheads). (d) Photograph of the 
cut surface of the excised specimen demonstrates friable fibrous tissue with hemorrhage.
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Figure 9. Well-differentiated liposarcoma in a 51-year-old man. (a) Axial T1-weighted MR image (550/9) of the left 
chest wall shows a mass (maximum diameter, ~7.5 cm) superficial to the rib cage. The mass is well defined but shows 
marginal invasion of adjacent muscle and of the rib cage (arrowheads). Most of the tumor has high signal intensity. 
However, a nonfat component (arrow) is also seen, suggesting the presence of a malignant component. (b) Axial 
gadolinium-enhanced fat-suppressed T1-weighted MR image (550/9) shows diffuse streaky and nodular enhancement 
of the nonfat region of the tumor (arrowhead). (c) Photomicrograph (original magnification, ×200; H-E stain) reveals 
fat vacuoles that vary greatly in size. Note the adipocytic nuclear atypia (arrowheads) within the collagenous stroma 
and the relatively high density of vessels, findings that are believed to have caused the prominent enhancement seen on 
gadolinium-enhanced T1-weighted MR images (cf b).
at cross-sectional imaging, and the differentia-
tion of sarcoma types frequently requires biopsy 
(7,26).
Adipocytic Tumors
Fatty tumors of the chest wall are relatively com-
mon, and although conventional lipoma is by far 
the most frequently encountered fatty soft-tissue 
tumor, there are a number of variants. In this 
article, however, we focus only on conventional 
lipoma and well-differentiated liposarcoma.
Lipoma.—Lipoma, the most common soft-tissue 
tumor, is most frequently observed in patients 
over 50 years of age. All lipomas are composed of 
adipose tissue, but various types of nonadipose 
tissue, such as connective tissue septa and calci-
fication, are present in one-third of these tumors 
(34,35). On gadolinium-enhanced MR images, 
lipomas typically do not enhance. However, septa 
less than 2 mm in thickness are often visible and 
may enhance mildly (34,35). Furthermore, many 
lipomas of the chest wall are deep seated and 
involve deep intermuscular or muscular layers 
(34,35).
Liposarcoma.—Liposarcoma is the second most 
common subtype of chest wall soft-tissue malig-
nancy after UPS (36). The WHO identifies five 
basic pathologic subtypes—well-differentiated, 
dedifferentiated, myxoid, pleomorphic, and 
mixed—and imaging findings of liposarcomas de-
pend on the subtype (7). Well-differentiated lipo-
sarcoma is the most common subtype, account-
ing for approximately 50% of lesions (37). The 
WHO classification system treats atypical lipoma-
tous tumor and well-differentiated liposarcoma as 
identical, since they share the same morphologic 
features, karyotype, and biologic behavior.
Typically, well-differentiated liposarcoma 
appears as a predominantly fatty lesion, with 
50%–75% of tumor volume demonstrating fat 
signal intensity, and the MR imaging features of 
well-differentiated liposarcoma are frequently 
characteristic. Well-differentiated liposarcoma has 
been reported to have characteristic MR imag-
ing features in 91%–96% of cases but to appear 
similar to lipoma in 4%–9% of cases (37). MR 
imaging features that suggest well-differentiated 
liposarcoma rather than lipoma include the pres-
ence of (a) prominent internal septa greater than 
2 mm in thickness, and (b) nodular nonadipose 
areas (35). The gadolinium enhancement of non-
adipose regions is variable (Fig 9) and has been 
described as ranging from mild to marked (35); 
however, one research group reported that the 
thick, irregular septa of liposarcomas enhance 
significantly in most cases, whereas thin septa 
enhance only faintly (38). Other histologic types 
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lesions with high numbers of normal- or abnor-
mal-appearing vessels. At pathologic analysis, 
hemangiomas can be subclassified according to 
the predominant type of vascular channel (capil-
lary, cavernous, arteriovenous, or venous) present 
within the lesion (40). However, subclassifica-
tion is frequently difficult due to admixtures of 
histologic components. Hemangiomas also com-
monly manifest with nonvascular elements, which 
include fat, smooth muscle, thrombus, fibrous 
tissue, and hemosiderin. Phleboliths (dystrophic 
calcifications of thrombi) are most frequently 
observed in cavernous hemangiomas but can also 
be present in other vascular lesions (41). One CT 
study found that 30% of cavernous hemangiomas 
contain a phlebolith (42). At T1- and T2-weighted 
imaging, hemangiomas typically demonstrate re-
gions of high signal intensity representing vascular 
tissue intermixed with variable (and sometimes 
substantial) amounts of fat (Fig 10) (7).
Figure 10. Capillary hemangioma in a 
34-year-old woman. (a) Axial T1-weighted 
MR image (600/9) of the left chest wall shows 
a mass (maximum diameter, ~12 cm) super-
ficial to the rib cage. Arrowhead indicates 
high-signal-intensity foci at the periphery of 
the mass, suggesting the presence of inter-
mingled fat tissue. (b) Axial fat-suppressed 
T2-weighted MR image (5000/120) shows the 
mass with high signal intensity and internal 
septa. (c) Photomicrograph (original magnifi-
cation, ×40; H-E stain) demonstrates numer-
ous vascular spaces filled with blood cells. 
Note the fat tissues (arrows), which can appear 
hyperintense on T1-weighted images (cf a).
of liposarcoma typically contain less fat (usually 
less than 25% of tumor volume at cross-sectional 
imaging) (7), and pleomorphic liposarcomas have 
been reported to demonstrate no fat on MR im-
ages in 62%–75% of cases (7,39).
Vascular Tumors
Vascular tumors include benign tumors (eg, 
hemangioma, lymphangioma), tumors show-
ing intermediate biologic behavior (eg, heman-
gioendothelioma), and malignant tumors (eg, 
angiosarcoma).
Hemangioma.—Hemangiomas are occasionally 
found in the soft tissue of the chest wall. Here, 
we use the term hemangioma in its broadest 
sense. Furthermore, we agree with other authors 
that these lesions represent benign nonreactive 
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Lymphangioma.—Lymphangioma is a congenital 
lesion that consists of dilated lymphatic vessels 
and is commonly encountered in the neck and 
axilla, although it is most commonly found at the 
cervicothoracic junction in children and in the 
mediastinum in adults (7). Lesions are usually 
present at birth (50%–65% of cases) and nearly 
always by 2 years of age (90%) (40). Lymphan-
gioma typically has low signal intensity similar to 
or less than that of muscle on T1-weighted MR 
images but high signal intensity greater than that 
of fat on T2-weighted images. There is thin pe-
ripheral and septal enhancement following gado-
linium administration (Fig 11) (40).
Intermediate and Malignant Vascular Tu-
mors.—Angiosarcoma is the most aggressive type 
of soft-tissue tumor arising from vascular tissue, 
and it usually affects adults. Chronic lymphedema 
is well known to predispose to angiosarcoma, 
although only approximately 10% of lesions 
demonstrate this association. The vast majority of 
angiosarcomas associated with lymphedema are 
found in postmastectomy patients (40). The imag-
ing features of malignant vascular tumors (angio-
sarcomas and Kaposi sarcomas) and those of vas-
cular tumors of intermediate aggressiveness (he-
mangioendotheliomas and hemangiopericytomas) 
are dependent on lesion location (ie, superficial 
or deep). Most superficial aggressive vascular tu-
mors are Kaposi sarcomas or angiosarcomas, and 
cross-sectional imaging reveals skin thickening 
and subcutaneous edema with an associated focal 
soft-tissue mass. On the other hand, deep-seated 
malignant vascular tumors or vascular tumors of 
intermediate aggressiveness are usually hemangio-
endotheliomas, hemangiopericytomas, or angio-
sarcomas, any of which may have the nonspecific 
imaging appearance of a solid mass (40).
Peripheral nerve Sheath Tumors
Neurogenic tumors of the chest wall arise from 
spinal nerve roots, intercostal nerves, and (some-
times) distal brachial plexus branches. The be-
nign group includes schwannomas and neurofi-
bromas; malignant PNSTs, a malignant counter-
part of these benign tumors, can also occur at the 
chest wall. The imaging features of these tumors 
are identical to those of similar tumors in other 
locations.
Schwannoma.—Schwannomas typically occur 
in patients between 20 and 50 years of age. They 
are almost invariably slow-growing nonaggressive 
neoplasms and usually manifest clinically as a 
painless mass (often <5 cm) without neurologic 
symptoms (43). Antoni A and Antoni B regions 
(Antoni A is a more organized hypercellular re-
gion composed of spindle cells, whereas Antoni 
B is a less organized hypocellular region demon-
strating myxoid components) are the histologic 
hallmarks of schwannoma. Large schwannomas 
commonly undergo degenerative changes and 
demonstrate cyst formation, hemorrhage, calci-
fication, and fibrosis. These features are far less 
common in neurofibroma (43).
Neurofibroma.—Neurofibromas most commonly 
develop in patients between 20 and 30 years of 
age and may demonstrate a localized, diffuse, or 
plexiform pattern. The localized type is by far the 
most common, representing approximately 90% 
of lesions, with the vast majority being solitary 
and not associated with neurofibromatosis type 
I. The diffuse type is associated with a plaquelike 
elevation of the skin and thickening of the entire 
Figure 11. Lymphangioma 
in a 19-year-old man. (a) Co-
ronal gadolinium-enhanced 
fat-suppressed T1-weighted 
MR image (600/9) of the left 
posterior chest wall shows a 
thin peripheral rim and septal 
enhancement suggestive of 
multilocular cystic spaces.  
(b) Coronal fat-suppressed 
T2-weighted MR image 
(3500/80) obtained at the same 
level reveals a hyperintense 
lesion (maximum diameter, ~6 
cm) with internal septa.
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subcutis. Plexiform neurofibromas diffusely in-
volve long segments of a nerve and its branches 
and have a “bag of worms” appearance. The 
histologic appearance of solitary localized neu-
rofibroma differs markedly from that of schwan-
noma. Neurofibromas do not contain Antoni A 
or Antoni B regions, and degenerative regions are 
not as prominent as in schwannomas (43). Fur-
thermore, unlike schwannomas, neurofibromas 
are intimately intermixed and inseparable from 
affected nerve tissues, so that complete excision 
requires sacrifice of the affected nerve (44). Con-
sequently, differentiation between these two enti-
ties is crucial, particularly when lesions are deep 
seated and involve nerves whose resection would 
cause severe functional compromise.
Imaging Features of Schwannoma vs Neuro-
fibroma.—MR imaging has been proposed for 
the differential diagnosis of PNSTs. The classic 
target sign seen at T2-weighted imaging consists 
of relatively low signal intensity at the center 
of a lesion together with high signal intensity 
at the periphery. Typically, the central lower-
signal-intensity region enhances on gadolinium-
enhanced MR images, whereas the peripheral 
high-signal-intensity region does not (Fig 12). 
These MR imaging features correspond to patho-
logic findings of fibrovascular tissue (with high 
collagen content) centrally and more myxoid tis-
sue peripherally (45). The target sign has been 
reported to be present at T2-weighted imaging 
in 50%–70% of neurofibromas and 0%–54% of 
schwannomas (45–47). Furthermore, the target 
sign on T2-weighted images and central enhance-
ment on gadolinium-enhanced T1-weighted im-
ages have been reported to favor a diagnosis of 
neurofibroma (63% of cases) rather than schwan-
noma (3%) (46). In addition, the fascicular sign 
is seen at T2-weighted imaging and consists of 
heterogeneous low signal intensity with a ringlike 
pattern (Fig 13). One study reported that the fas-
cicular sign was present in 63% of schwannomas 
and 25% of neurofibromas (47). However, there 
is considerable overlap between the imaging fea-
tures of these two disease entities.
Malignant PNST.—Malignant PNSTs account 
for 5%–10% of all soft-tissue sarcomas and af-
fect adults between 20 and 50 years of age. They 
are associated with neurofibromatosis type I in 
25%–70% of cases and show a distinct propen-
sity for affecting major or medium-sized nerves, 
including the sciatic nerve and the brachial and 
sacral plexuses. Differentiation between a malig-
nant PNST and a benign neurogenic tumor is 
not difficult when the tumor is sufficiently large 
and infiltrative (Fig 14). However, it is not easy 
to differentiate a large, infiltrative malignant 
PNST from other sarcomas, unless the mass 
demonstrates certain imaging features, such as a 
location along the course of a large nerve or an 
intermuscular distribution (“split fat sign”) (48). 
Figure 12. Neurofibroma in a 37-year-old woman. (a) Axial gadolinium-enhanced fat-suppressed T1-weighted 
MR image (600/9) obtained at the level of the end of the scapula (S) shows a lesion with central enhancement (ar-
row) and peripheral hypoenhancement (arrowheads). (b) Axial fat-suppressed T2-weighted MR image (5000/120) 
obtained at the same level shows a well-circumscribed mass. The central portion of the mass (arrow) has heteroge-
neous low signal intensity, whereas the tumor periphery (arrowheads) has high signal intensity, creating the so-called 
target sign. S = scapula. (c) Photograph of the cut surface of the excised specimen shows a well-circumscribed, yel-
lowish myxoid mass (arrowheads) with central fibrovascular tissue (arrow), findings that correspond to the target 
sign seen at MR imaging.
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Figure 13.  Schwannoma in a 66-year-
old man. (a) Axial fat-suppressed T2-
weighted MR image (3500/80) shows a 
well-circumscribed mass lateral to the rib 
cage. Diffusely scattered areas of hetero-
geneous signal intensity with a ringlike 
pattern (arrowheads) are seen against a 
hyperintense tumor background (fascicu-
lar sign). (b) Photomicrograph (original 
magnification, ×100; H-E stain) exhibits 
an Antoni A zone of hypercellularity 
composed of spindle cells (arrow) and an 
Antoni B zone of hypocellularity demon-
strating myxoid components (arrowhead).
Furthermore, the differentiation of malignant 
PNSTs from benign neurogenic tumors is some-
times difficult. MR imaging findings that favor a 
diagnosis of malignant PNST include a size over 
5 cm, the absence of the target sign or fascicular 
sign, the presence of an ill-defined margin, and 
rapid interval growth on follow-up images (43).
Cutaneous lesions
When imaging seems to indicate that a lesion 
originated from cutaneous tissue, the differen-
tial diagnosis includes epidermal inclusion cyst, 
pilomatricoma, and dermatofibrosarcoma pro-
tuberans (DFSP), along with cutaneous heman-
gioma and granuloma annulare, which are not 
discussed in this article.
Epidermal Inclusion Cyst.—Epidermal inclusion 
cysts result from a proliferation of epidermal cells 
within a circumscribed dermal space. The dermal 
space fills with keratin debris and is bounded by 
a wall of stratified squamous epithelium, result-
ing in the formation of a cyst. Epidermal inclu-
sion cysts involve the scalp, face, neck, trunk, 
and back in more than 90% of cases (49) and are 
frequently observed on the chest wall. These cysts 
demonstrate characteristic MR imaging findings, 
including (a) a well-demarcated mass with vari-
able low signal intensity with or without a cystlike 
high-signal-intensity background on T2-weighted 
images, (b) hyperintense foci on T1-weighted im-
ages, and (c) peripheral thin rim enhancement. It 
has been suggested that the hyperintense foci ob-
served on T1-weighted images represent calcium 
components. The variable low signal intensity ob-
served on T2-weighted images has been reported 
to be due to various components contained 
within the cyst (Fig 15). These characteristics, 
which are not typical of other masses with high 
water content, help differentiate epidermal inclu-
sion cysts from other cystic lesions (50).
Figure 14. Malignant PNST in a 43-year-old 
woman who was referred for management of 
a large mass (maximum diameter, ~13 cm) at 
the neck wall that had grown through the up-
per chest wall. Coronal T2-weighted MR image 
(4000/80) obtained at the level of the thoracic 
inlet reveals a dumbbell-shaped mass with het-
erogeneous signal intensity.
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intensity on T2-weighted images, and they are 
considered to be covered with a connective tissue 
capsule, which enhances after gadolinium admin-
istration. However, the center of the lesion does 
not enhance prominently, with the exception of 
septa. Peritumoral edema or inflammation can 
also be identified at MR imaging (Fig 16). Cal-
cium deposition commonly occurs in the shadow 
cell region and stroma (69%–85% of cases) (53). 
When calcification occurs, the radiologic dif-
ferential diagnosis includes a calcified lymph 
node, ossifying hematoma, and hemangioma 
with phlebolith. Granuloma annulare and DFSP, 
both of which have a superficial location, are also 
included in the differential diagnosis, but both 
manifest as soft-tissue masses without calcifica-
tion (54).
Dermatofibrosarcoma Protuberans.—DFSP is 
an uncommon spindle cell tumor that arises in 
the dermis and typically spreads into subcutane-
ous tissues and muscles. It is no longer classified 
as a soft-tissue tumor by the WHO, but rather as 
Figure 15. Epidermal inclusion cyst in a 
47-year-old woman. (a) Axial gadolinium-
enhanced fat-suppressed T1-weighted MR im-
age (450/9) obtained at the level of the upper 
posterior chest wall shows a mass with peripheral 
rim enhancement (arrowheads). (b) Axial T2-
weighted MR image (5000/120) obtained at the 
same level reveals a well-circumscribed mass 
(arrowheads). Note that the mass is not hyper-
intense. (c) Photomicrograph (original magni-
fication, ×100; H-E stain) shows a squamous 
epithelium lining (arrowheads). * indicates a 
cystic space filled with layered keratin (arrows), a 
finding that partly explains the absence of hyper-
intensity seen in b.
Pilomatricoma.—Pilomatricomas, formerly 
known as pilomatrixomas, are benign subcutane-
ous tumors that arise from hair matrix and are 
most commonly found in children and young 
adults (51). They are typically located on the 
head and neck (68% of cases), with 29% seen 
on the trunk and 17% on the extremities (52). 
Pilomatricomas have a superficial location and 
typically manifest as subcutaneous or dermal 
nodules. At pathologic analysis, they are seen 
to consist of epithelial cells with basophilic cy-
toplasm arranged in an arclike fashion at the 
periphery (basaloid cells). In time, these cells 
are transformed into shadow cells (also known 
as ghost cells), which are more centrally located. 
These eosinophilic cells have no nuclei and are 
filled with keratin. The intracellular stroma is col-
lagenous and contains dilated blood vessels (53). 
Pilomatricomas typically have homogeneous in-
termediate signal intensity on T1-weighted MR 
images and heterogeneous intermediate signal 
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a skin tumor (3). Because of the layer in which 
this entity occurs, we consider it to be a soft-
tissue tumor originating from a cutaneous layer. 
The trunk is the most common site of involve-
ment (almost 50% of cases) (55). DFSP typically 
occurs in adolescents, although it may occur 
much later in life. At CT, this tumor manifests as 
a well-defined nodular subcutaneous lesion with-
out calcification. MR imaging findings of DFSP 
vary from a small nodule to a large mass abutting 
the dermis. The intrinsic MR imaging findings 
are nonspecific and include hypointensity on 
T1-weighted images (Fig 17) and hyperintensity 
relative to fat on T2-weighted images (56). DFSP 
lesions may include heterogeneous foci of hemor-
rhage, myxoid change, or necrosis (55).
Figure 16. Pilomatricoma in a 9-year-old boy. (a) Sagittal gadolinium-enhanced fat-suppressed T1-weighted MR 
image (550/9) obtained at the level of the upper posterior chest wall shows a nodule with diffuse reticular enhance-
ment. Note the intense enhancement of the fibrous capsule at the periphery on the dermal side of the lesion (arrow-
heads). (b) Sagittal T2-weighted MR image (3000/90) obtained adjacent to a shows a well-circumscribed subcuta-
neous nodule that is hyperintense relative to adjacent muscle. The increased signal intensity surrounding the nodule 
(arrowheads) suggests peritumoral edema. (c) Photomicrograph (original magnification, ×12; H-E stain) reveals 
nucleated basaloid cells (arrowheads) under a capsule of compressed fibrous tissue (arrows) deep to the dermis (*). 
The fibrous capsule corresponds to the area of enhancement seen at the lesion periphery in a.
Figure 17. DFSP in a 46-year-old 
woman. (a) Sagittal gadolinium-en-
hanced fat-suppressed T1-weighted 
MR image (550/9) shows an in-
tensely enhancing nodule at the pos-
terior chest wall that extends along 
and invades the deep layer of the 
dermis (arrowhead). (b) Photograph 
of the cut surface of the excised 
specimen shows ill-defined whitish 
tumor tissue (arrowhead) extending 
along the deep layer of the dermis, a 
finding that corresponds to the lin-
ear enhancing lesion seen in a.
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Fibroblastic-Myofibroblastic Tumors
Of the numerous fibroblastic-myofibroblastic tu-
mors, we discuss two in this article: elastofibroma 
dorsi and fibromatosis.
Elastofibroma Dorsi.—Elastofibroma dorsi is a 
pseudotumor of the soft tissue with a 4:1 female 
predilection. The average patient age at onset is 
60 years (range, 41–80 years). In one investiga-
tion, most lesions (93%) were reported to occur 
in deep dorsal regions between the thoracic wall 
and the lower third of the scapula under the ser-
ratus anterior and latissimus dorsi muscles (57). 
These lesions are often asymptomatic, and bi-
laterality is common (10%–66% of cases) (58). 
At MR imaging, elastofibroma dorsi typically 
manifests as a mass with a signal intensity similar 
to that of muscle on both T1- and T2-weighted 
images, with interspersed streaks of fat in a fas-
cicular pattern (Fig 18) (59).
Fibromatosis.—Fibromatosis, or desmoid tu-
mor, is considered to be a true neoplasm and 
is composed of well-differentiated fibroblasts 
embedded in an abundant collagenous matrix 
with increased cellularity at the periphery (60). 
It arises from connective tissue in muscle, fascia, 
or aponeurosis, or sometimes at the site of a trau-
matic or postsurgical scar. Generally, fibromatosis 
is poorly circumscribed, nonencapsulated, and 
infiltrative, and grows insidiously. Although the 
lesion is locally aggressive, it is not malignant and 
does not metastasize. The chest wall has been 
reported to be the site of origin in 10%–28% of 
cases (9). Fibromatosis often affects adolescents 
and young adults (Fig 19) but may also occur in 
older patients. At CT, fibromatosis may be poorly 
defined, suggesting aggressiveness, and may show 
variable attenuation and enhancement owing to 
varying degrees of cellularity, matrix water con-
tent, and infiltration (61). At MR imaging, fibro-
matosis usually has heterogeneous signal inten-
sity, which probably reflects different amounts 
and distributions of spindle-shaped cells, extra-
cellular collagen, and myxoid matrix. In one re-
port, T2-weighted imaging depicted hypointense 
bands in 86% of cases of fibromatosis, a finding 
that probably corresponded to dense conglomer-
ations of collagen bundles, which were observed 
histologically (62). These collagen bundles do 
not enhance after contrast material administra-
tion, although tumors typically show moderate to 
marked heterogeneous enhancement (63).
So-called Fibrohistiocytic Tumors
UPS is classified as a fibrohistiocytic tumor by 
the WHO (3). It is a pleomorphic soft-tissue sar-
coma that arises in deep fascia or skeletal muscle 
and is the most common malignant soft-tissue 
tumor in adults (58), although its imaging fea-
tures are nonspecific. It tends to be found on the 
thigh, on the trunk, or in the retroperitoneum, 
but is found only rarely at the chest wall. Clini-
cal cases show a slight female predilection and a 
mean patient age of 55 years at onset (64). Ac-
cording to the WHO classification system, there 
are three histologic subtypes of UPS: high-grade 
pleomorphic sarcoma, pleomorphic sarcoma with 
giant cells, and pleomorphic sarcoma with promi-
nent inflammation.
Before describing the imaging features of UPS, 
we should address myxoid malignant fibrous his-
tiocytoma, which was previously considered to 
Figure 18. Elastofibroma in a 
78-year-old woman. (a) Axial 
gadolinium-enhanced fat-sup-
pressed T1-weighted MR im-
age (550/9) shows a crescent-
shaped soft-tissue lesion with 
diffuse streaky enhancement 
(arrows) in the deep dorsal 
region between the thoracic 
wall and the lower third of the 
scapula. (b) On an axial T2- 
weighted MR image (4500/120), 
the mass (arrows) is mostly 
isointense relative to adjacent 
muscle, with interspersed 
streaks of hyperintense fat.
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be a subtype of UPS. Myxoid malignant fibrous 
histiocytoma is now referred to as myxofibrosar-
coma and is categorized as a fibroblastic-myo-
fibroblastic tumor rather than a fibrohistiocytic 
tumor (37). However, we describe the imaging 
findings of UPS and myxofibrosarcoma together 
Figure 19. Fibromatosis in a 19-year-old 
woman. (a) Axial gadolinium-enhanced fat-
suppressed T1-weighted MR image (650/9) 
obtained at the level of the clavicle shows a 
mass with diffuse intense but heterogeneous 
enhancement (arrow) and obvious infiltra-
tion into the adjacent pectoralis major muscle 
(arrowhead). (b) Axial fat-suppressed T2-
weighted MR image (3500/95) obtained at 
the same level shows the mass (arrow) with 
intermediate signal intensity. The signal voids 
within the mass are suggestive of fibrous col-
lagen bands. (c) Photograph of the cut sur-
face of the excised specimen shows the mass 
with a lobular contour (arrowheads) and a 
white-gray rubbery texture. Note the infiltra-
tion of whitish fibrous tissues into adjacent 
muscle (arrows). (d) Photomicrograph (origi-
nal magnification, ×200; H-E stain) shows 
fibroblasts (black arrows) scattered through-
out a background of collagenous fibers (white 
arrows). Note the smooth muscle cells (ar-
rowheads), which suggest tumor infiltration 
of the adjacent muscle.
because these findings overlap, although they 
sometimes reflect histologic differences.
At CT, UPS manifests as nonspecific, hetero-
geneously enhancing masses in muscle and fascial 
planes, whereas myxofibrosarcoma typically dem-
onstrates a hypoattenuating central region with 
peripheral nodular enhancement, reflecting a 
central myxoid matrix and greater peripheral cel-
lularity (9). Although calcification or ossification 
has been reported at the lesion periphery in a 
small percentage of cases of UPS, calcification is 
generally considered unusual except in previously 
treated cases (9,27,64). At MR imaging, the sig-
nal intensity of soft-tissue fibrous malignancies 
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is typically intermediate to low on T1-weighted 
images and intermediate to high on T2-weighted 
images (Fig 20). Variations in signal intensity 
are believed to correlate with various fibrous tis-
sue components with high collagen content (low 
signal intensity with all pulse sequences), myxoid 
tissue (low signal intensity on T1-weighted images 
and high signal intensity on T2-weighted images), 
and hemorrhage (variable signal intensity) (37).
Summary
The presence of a bone lesion in the chest wall 
with locally aggressive features and mineraliza-
tion suggests the diagnosis of chondrosarcoma, 
whereas nonmineralization should raise suspicion 
for metastasis or myeloma. A benign-appearing 
bone lesion involving the chest wall should ini-
tially be considered to represent fibrous dyspla-
sia or osteochondroma. In primary soft-tissue 
masses of the chest wall, MR imaging findings of 
thick septa, nodular enhancement on contrast-
enhanced T1-weighted images, and a nonadi-
pose component involving more than 25% of 
the mass favor a diagnosis of liposarcoma rather 
than lipoma. The target sign and fascicular sign 
are useful MR imaging findings of PNST but 
are not pathognomonic for neurofibroma or 
schwannoma, respectively, and do not allow the 
differentiation of benign from malignant PNSTs. 
Serpentine vascular channels, phleboliths, and fat 
foci are diagnostic for hemangioma. A superficial 
aggressive tumor associated with lymphedema 
suggests angiosarcoma. Subcutaneous lesions 
that originate from the skin suggest epidermal 
inclusion cyst, pilomatricoma, or DFSP as a 
likely diagnosis. On the other hand, elastofibroma 
occurs at the lower tip of the scapula and is likely 
to be bilateral.
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Chondrosarcoma is the most common primary malignant bone tumor of the chest wall and accounts 
for 33% of all primary rib tumors, with myeloma being the second most common. Ewing sarcoma is the 
most common primary bone tumor in children (1,8–10). Fibrous dysplasia is the most common benign 
tumorous condition of the osseous chest wall, accounting for approximately 30% of these tumors (11).
Page 757
However, enchondroma is generally considered to occur only rarely on the chest wall (7,26); chondrosar-
coma is much more common. Hence, a destructive osseous lesion of the chest wall is initially suspected 
by the radiologist to be chondrosarcoma when mineralization is present (27).
Page 758
In adults, the most common benign soft-tissue neoplasm is lipoma, and the most common malignant 
neoplasm is undifferentiated pleomorphic sarcoma (UPS), a term that is used interchangeably with ma-
lignant fibrous histiocytoma. In children, rhabdomyosarcoma and primitive neuroectodermal tumor (Askin 
tumor) are the most common malignant soft-tissue tumors (26).
Page 759 (Figure on page 759)
MR imaging features that suggest well-differentiated liposarcoma rather than lipoma include the pres-
ence of (a) prominent internal septa greater than 2 mm in thickness, and (b) nodular nonadipose areas 
(35). The gadolinium enhancement of nonadipose regions is variable (Fig 9) and has been described as 
ranging from mild to marked (35); however, one research group reported that the thick, irregular septa of 
liposarcomas enhance significantly in most cases, whereas thin septa enhance only faintly (38).
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Calcium deposition commonly occurs in the shadow cell region and stroma (69%–85% of cases) (53). 
When calcification occurs, the radiologic differential diagnosis includes a calcified lymph node, ossify-
ing hematoma, and hemangioma with phlebolith. Granuloma annulare and DFSP, both of which have a 
superficial location, are also included in the differential diagnosis, but both manifest as soft-tissue masses 
without calcification (54).
